Data / Form D filings / NGM Bio Holdings, Inc.
NGM Bio Holdings, Inc.: Form D filings
NGM Bio Holdings, Inc., a biotechnology company in South San Francisco, CA, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on March 27, 2026, reports $142 million sold of a $142 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 611 Gateway Blvd., Suite 540, South San Francisco, CA, 94080
- Phone
- (650) 243-5555
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2029767
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Amendment | $142,039,949 | $142,039,949 | 26 | Jul 5, 2024 | sec.gov | |
| Jul 17, 2024 | New notice | $122,039,949 | $73,223,979 | $48,815,970 | 25 | Jul 5, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Roger M. Perlmutter | Director | |
| Peter Svennilson | Director | |
| Diana Peng Bockus | Executive Officer, Director | |
| Tim Kutzkey | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 23, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NGM Bio Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.